Melanoma treatment with a novel irreversible isoform-specific ALDH1 inhibitor (DIMATE) or depletion of ALDH1A1 and/or ALDH1A3 results in the accumulation of toxic aldehydes, increased apoptosis, and decreased tumor growth in xenograft mouse models [190]. This evidence concerns the gene ALDH1A1 and melanoma.